Morgan Stanley Immix Biopharma, Inc. Transaction History

Morgan Stanley

$1.49 Trillion
Q2 2025

A detailed history of Morgan Stanley transactions in Immix Biopharma, Inc. stock. As of the latest transaction made, Morgan Stanley holds 124,919 shares of IMMX stock, worth $309,799. This represents 0.0% of its overall portfolio holdings.

Number of Shares

124,919

Previous 82,292 51.8%

Holding current value

$309,799

Previous $138,000 86.96%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 15, 2025	BUY	$1.36 - $2.6 $57,972 - $110,830	42,627 Added 51.8%	124,919 $258,000
Q1 2025 May 15, 2025	SELL	$1.52 - $2.35 $13,313 - $20,583	-8,759 Reduced 9.62%	82,292 $138,000
Q4 2024 Feb 14, 2025	BUY	$1.38 - $2.54 $9,298 - $17,114	6,738 Added 7.99%	91,051 $208,000
Q3 2024 May 14, 2025	BUY	$1.49 - $2.45 $38,525 - $63,347	25,856 Added 44.23%	84,313 $125,000
Q3 2024 Nov 14, 2024	BUY	$1.49 - $2.45 $38,525 - $63,347	25,856 Added 44.23%	84,313 $125,000
Q2 2024 May 14, 2025	SELL	$1.81 - $3.06 $58,995 - $99,737	-32,594 Reduced 35.8%	58,457 $115,000
Q2 2024 Oct 17, 2024	BUY	$1.81 - $3.06 $7,985 - $13,500	4,412 Added 8.16%	58,457 $115,000
Q2 2024 Aug 14, 2024	BUY	$1.81 - $3.06 $7,985 - $13,500	4,412 Added 8.16%	58,457 $115,000
Q1 2024 Oct 17, 2024	SELL	$2.64 - $6.68 $11,647 - $29,472	-4,412 Reduced 7.55%	54,045 $165,000
Q1 2024 Aug 16, 2024	BUY	$2.64 - $6.68 $99,995 - $253,018	37,877 Added 234.27%	54,045 $165,000
Q1 2024 May 15, 2024	BUY	$2.64 - $6.68 $99,995 - $253,018	37,877 Added 234.27%	54,045 $165,000
Q4 2023 Aug 16, 2024	SELL	$2.82 - $7.27 $119,254 - $307,441	-42,289 Reduced 72.34%	16,168 $111,000
Q4 2023 Feb 13, 2024	BUY	$2.82 - $7.27 $44,465 - $114,633	15,768 Added 3942.0%	16,168 $111,000
Q3 2023 Nov 15, 2023	BUY	$1.63 - $3.68 $652 - $1,472	400 New	400 $1,000
Q4 2022 Feb 14, 2023	SELL	$0.75 - $2.43 $1 - $4	-2 Reduced 66.67%	1 $0
Q3 2022 Nov 14, 2022	BUY	$1.36 - $3.05 $4 - $9	3 New	3 $0

Others Institutions Holding IMMX

# of Institutions

Shares Held

2.67M

Call Options Held

Put Options Held

View Full List

About Immix Biopharma, Inc.

Ticker IMMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,910,100
Market Cap $34.5M
Description
Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing various tissue-specific therapeutics in oncology and inflammation in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and solid tumors; IMX-111, a tissue-specif...

More about IMMX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account